Last reviewed · How we verify
Pneumococcal pharyngitis
Approved treatments
- Unasyn · Bristol-Myers Squibb
- E-Mycin · Generic (originally Abbott/Lilly)
- Benzamycin · Pfizer
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Pneumococcal pharyngitis patent landscape — cliff calendar, originator estates, attackable patents
- Pneumococcal pharyngitis treatment landscape brief
- Pneumococcal pharyngitis treatment updates RSS
Frequently asked questions about Pneumococcal pharyngitis
What drugs treat Pneumococcal pharyngitis?
Tracked treatments include Unasyn, E-Mycin, Benzamycin.
What is the treatment for Pneumococcal pharyngitis?
Standard treatment for Pneumococcal pharyngitis includes Unasyn, E-Mycin, Benzamycin. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Pneumococcal pharyngitis patent cliff · Pneumococcal pharyngitis CI report
- Treatment: Unasyn · Bristol-Myers Squibb
- Treatment: E-Mycin · Generic (originally Abbott/Lilly)
- Treatment: Benzamycin · Pfizer
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing